R
RPRX
Royalty Pharma Plc
53.86
-0.64-1.17%Pre Market: 53.85 -0.01 -0.02%04:00 05/27 EDT
OPEN/PREV CLOSE54.72/54.50
TODAY RANGE53.63-54.74
VOL35
MARKET CAP31.01B
52 WEEK RANGE31.53-54.74
AVG VOL (3M)3.34M
% TURNOVER0.48%
TURNOVER--
P/E (TTM)28.22
% RANGE2.02%
EPS(TTM)1.909
P/E(FORWARD)17.43
P/B4.505
BVPS11.96
DIVIDEND0.9400
P/S13.07
BETA--
DIV YIELD1.75%
FREE FLOAT MKT CAP22.16B
SHARES OUTSTANDING575.83M
NEXT EARNINGS08/04-08/10
FREE FLOAT411.47M
LOT SIZE1
EX-DATE05/15/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·05/16 07:12
Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead
Simply Wall St·05/14 12:34
Royalty Pharma (RPRX) Valuation Check After Strong Q1 Earnings And Rising Investor Interest
Simply Wall St·05/10 16:21
Accelerated Royalty Deals and Dividend Hike Could Be A Game Changer For Royalty Pharma (RPRX)
Dow Jones·05/07 21:04
Royalty Pharma Price Target Raised to $66.00/Share From $50.00 by Citigroup
Dow Jones·05/07 21:04
Royalty Pharma Is Maintained at Buy by Citigroup
Benzinga·05/07 20:54
Citigroup Maintains Buy on Royalty Pharma, Raises Price Target to $66
Dow Jones·05/07 19:53
Royalty Pharma Is Maintained at Overweight by JP Morgan
Dow Jones·05/07 19:53
Royalty Pharma Price Target Raised to $58.00/Share From $50.00 by JP Morgan
Benzinga·05/07 19:44
JP Morgan Maintains Overweight on Royalty Pharma, Raises Price Target to $58
TipRanks·05/07 19:05
Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
Same Industry
Name/Symbol
Change%
Price